Leptin in Leanness and Obesity: JACC State-of-the-Art Review

J Am Coll Cardiol. 2021 Feb 16;77(6):745-760. doi: 10.1016/j.jacc.2020.11.069.

Abstract

Leptin has emerged over the past 2 decades as a key hormone secreted by adipose tissue that conveys information on energy stores. Leptin is considered an important regulator of both neuroendocrine function and energy homeostasis. Numerous studies (mainly preclinical and much less in humans) have investigated the mechanisms of leptin's actions both in the healthy state as well as in a wide range of metabolic diseases. In this review, the authors present leptin physiology and review the main findings from animal studies, observational and interventional studies, and clinical trials in humans that have investigated the role of leptin in metabolism and cardiometabolic diseases (energy deficiency, obesity, diabetes, cardiovascular diseases, nonalcoholic fatty liver disease). The authors discuss the similarities and discrepancies between animal and human biology and present clinical applications of leptin, directions for future research, and current approaches for the development of the next-generation leptin analogs.

Keywords: CVD; NAFLD; appetite; diabetes; dyslipidemia; hypertension.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Clinical Trials as Topic
  • Humans
  • Leptin / deficiency
  • Leptin / physiology*
  • Leptin / therapeutic use
  • Obesity / metabolism*
  • Thinness / metabolism*

Substances

  • Leptin